Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.15M Buy
36,160
+980
+3% +$33.9K 0.09% 196
2022
Q2
$1.12M Buy
35,180
+6,390
+22% +$215K 0.09% 202
2022
Q1
$1.05M Buy
28,790
+1,050
+4% +$39.3K 0.07% 239
2021
Q4
$1.19M Buy
27,740
+450
+2% +$17.4K 0.08% 208
2021
Q3
$913K Buy
27,290
+1,110
+4% +$37.1K 0.07% 227
2021
Q2
$849K Buy
26,180
+1,800
+7% +$57.7K 0.06% 236
2021
Q1
$805K Buy
24,380
+2,160
+10% +$65.1K 0.07% 224
2020
Q4
$576K Sell
22,220
-15,470
-41% -$361K 0.06% 252
2020
Q3
$730K Sell
37,690
-2,740
-7% -$54.1K 0.08% 201
2020
Q2
$787K Sell
40,430
-8,290
-17% -$142K 0.1% 192
2020
Q1
$700K Sell
48,720
-14,760
-23% -$238K 0.11% 161
2019
Q4
$1.13M Buy
63,480
+41,970
+195% +$704K 0.14% 157
2019
Q3
$343K Sell
21,510
-880
-4% -$12.3K 0.05% 328
2019
Q2
$265K Buy
22,390
+1,310
+6% +$15.1K 0.04% 322
2019
Q1
$252K Buy
+21,080
New +$227K 0.04% 307

Other funds holding KLAC

Corient Capital Partners's KLAC Position: Q3 2022 in Review

Corient Capital Partners increased its KLA (KLAC) stake by 2.8% in Q3 2022, buying an estimated $33.9K and bringing the position to 36,160 shares worth $1.15M. The position accounts for 0.09% of the portfolio, ranked #196.

Corient Capital Partners first reported a position in KLAC in Q1 2019 and has held it in 15 quarters since. The position peaked at $1.19M in Q4 2021. 1,057 funds tracked by Wall St. Rank hold KLAC as of Q3 2022.

  • Corient Capital Partners held 36,160 shares of KLA worth $1.15M as of Q3 2022.
  • Corient Capital Partners bought 980 KLA shares in Q3 2022, an estimated $33.9K.
  • KLA made up 0.09% of Corient Capital Partners's portfolio in Q3 2022, its #196 holding.
  • Corient Capital Partners first reported a position in KLA in Q1 2019 and has held it in 15 quarters since.
  • Corient Capital Partners's KLA position peaked at $1.19M in Q4 2021.
  • 1,057 funds tracked by Wall St. Rank held KLA as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.